Quality of life in schizophrenia: Impact of psychopathology, patients' gender and antipsychotic treatment

International Journal of Psychiatry in Clinical Practice

Volumn 5, Issue 1, 2001, Pages 19-26

  Jarema, M ^a   Konieczynska Z ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Psychopharmacology; Quality of life; Schizophrenia

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; SULPIRIDE;

DISEASE SEVERITY; EXTRAPYRAMIDAL SYMPTOM; GENDER; HUMAN; MENTAL DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REVIEW; SCHIZOPHRENIA;

EID: 0035043603     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.1080/13651500152048414     Document Type: Review

References (30)

1. Measures of quality of life among persons with severe and persistent mental disorders
2. Comparison of quality of life with standard of living in schizophrenic outpatients
3. What do we mean by quality of life and how do we measure it in patients with schizophrenia?
4. Assessing the quality of life of the long-term mentally ill: A comparative study of two measures
5. Erlebnisse der lebensqualitätsforschung bei chronisch psychisch kranken
6. Methodological problems in assessing quality of life as outcome in psychopharmacology: A multiaxial approach
7. Subjective response to neuroleptics and the quality of life: Implications for treatment outcome
8. The quality of life scale: An instrument for rating the schizophrenic deficit syndrome
9. Evaluation of the quality of life of the schizophrenic outpatient: A checklist
10. Quality of life measurements during antipsychotic drug therapy of schizophrenia
11. The MOS 36-item short form health survey. Reliability, validity, and preliminary findings in schizophrenic outpatients
12. Changes in perceived health and functioning as a cost-effectiveness measure for olanzapine versus haloperidol treatment of schizophrenia
13. Reliability, validity, and application of the medical outcomes study 36-item short-form health survey (SF-36) in schizophrenic patients treated with olanzapine versus haloperidol
14. Measuring health status in psychiatric community surveys: Internal and external validity of the Spanish version of the SF-36
15. The positive and negative syndrome scale (PANSS) for schizophrenia
16. The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection
17. Comparison of quality of life of schizophrenic patients in different forms of psychiatric care
18. The evaluation of subjective quality of life in patients with schizophrenia or depression
19. Neuropsychiatric correlates of quality of life in schizophrenia
20. Quality of life in chronically mentally ill patients in day treatment
21. Evaluation of health-related quality of life in schizophrenic patients from day hospital
22. Quality of life in schizophrenia: Relationship to sociodemographic factors, symptomatology and tardive dyskinesia
23. Conventional versus atypical neuroleptics: Subjective quality of life in schizophrenic patients
24. The effect of risperidone on quality of life
25. Predictors of quality of life in schizophrenia
26. Employment, attitudes toward work, and quality of life among people with schizophrenia in three countries
27. Quality of life, loneliness, and social contact among long-term psychiatric patients
28. Subjective quality of life in out-patients with schizophrenia: Clinical and utilization correlates
29. Characterizing quality of life among patients with chronic mental illness: A critical examination of the self-report methodology
30. Schizophrenie und lebensqualität- geschlechtsspezifische aspekte